UY27599A1 - DIRECTLY COMPRESSIBLE ACITHROMYCIN FORMULATIONS - Google Patents
DIRECTLY COMPRESSIBLE ACITHROMYCIN FORMULATIONSInfo
- Publication number
- UY27599A1 UY27599A1 UY27599A UY27599A UY27599A1 UY 27599 A1 UY27599 A1 UY 27599A1 UY 27599 A UY27599 A UY 27599A UY 27599 A UY27599 A UY 27599A UY 27599 A1 UY27599 A1 UY 27599A1
- Authority
- UY
- Uruguay
- Prior art keywords
- acithromycin
- tablet
- formulations
- mga
- pharmaceutically acceptable
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere a una mezcla en seco, utilizada para formar comprimidos de acitromicina por compresión directa, que comprende acitromicina no dihidratada y al menos un excipiente farmacéuticamente aceptable. Esta invención se refiere también a un comprimido de acitromicina que comprende acitromicina no dihidratada y al menos un excipiente farmacéuticamente aceptable. Preferiblemente, el comprimido de acitromicina se forma mediante compresión directa de la mezcla en seco, de la presente invención, para formar dicho comprimido de acitromicina. Preferiblemente, el comprimido de acitromicina, de la presente invención, contiene una dosificación de 250 mgA, 500 mgA ó 600 mgA de acitromicina. Esta invención se refiere además a un comprimido de acitromicina que se produce formando una mezcla en seco de una forma A de acitromicina no granulada, y al menos un excipiente farmacéuticamente aceptable. El comprimido de acitromicina se forma a continuación mediante compresión directa de la mezcla en seco.The present invention relates to a dry mix, used to form acythromycin tablets by direct compression, which comprises undihydrated acithromycin and at least one pharmaceutically acceptable excipient. This invention also relates to an acithromycin tablet comprising undihydrated acithromycin and at least one pharmaceutically acceptable excipient. Preferably, the acithromycin tablet is formed by direct compression of the dry mix of the present invention to form said acithromycin tablet. Preferably, the acithromycin tablet of the present invention contains a dosage of 250 mgA, 500 mgA or 600 mgA of acithromycin. This invention further relates to an acithromycin tablet that is produced by forming a dry mixture of a non-granulated form of acithromycin A, and at least one pharmaceutically acceptable excipient. The acithromycin tablet is then formed by direct compression of the dry mixture.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UY27599A UY27599A1 (en) | 2002-12-20 | 2002-12-20 | DIRECTLY COMPRESSIBLE ACITHROMYCIN FORMULATIONS |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UY27599A UY27599A1 (en) | 2002-12-20 | 2002-12-20 | DIRECTLY COMPRESSIBLE ACITHROMYCIN FORMULATIONS |
Publications (1)
Publication Number | Publication Date |
---|---|
UY27599A1 true UY27599A1 (en) | 2003-07-31 |
Family
ID=38812723
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY27599A UY27599A1 (en) | 2002-12-20 | 2002-12-20 | DIRECTLY COMPRESSIBLE ACITHROMYCIN FORMULATIONS |
Country Status (1)
Country | Link |
---|---|
UY (1) | UY27599A1 (en) |
-
2002
- 2002-12-20 UY UY27599A patent/UY27599A1/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR037930A1 (en) | DIRECTLY COMPRESSIBLE ACITHROMYCIN FORMULATIONS | |
CY1122259T1 (en) | RAPID DISSOLVATION PHARMACEUTICAL FORM CONTAINING SINACALCET HCL | |
AR036643A1 (en) | ORGANIC COMPOUNDS | |
ECSP088499A (en) | NEW COMPOUNDS OF 2-AMINO-IMIDAZOL-4-ONA AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR USE IN THE TREATMENT OF COGNITIVE ALTERATION, ALZHEIMER'S DISEASE, NEURODEGENERATION AND DEMENTIA | |
UY28931A1 (en) | USED PIRROLOTRIAZINE DERIVATIVES TO TREAT HYPER-PROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS | |
MY157661A (en) | Bendamustine pharmaceutical compositions | |
WO2007016563A3 (en) | Alcohol resistant pharmaceutical formulations | |
WO2004000197A3 (en) | Quick dissolve compositions and tablets based thereon | |
CO5190672A1 (en) | COMPOSITION FOR ORAL DOSAGE, INSTANT DISSOLUTION | |
ES2181417T3 (en) | FORMULATION OF CAPSULES OR TABLETS OF EFAVIRENZ OF FAST DISSOLUTION USING SUPER-DISINTEGRANTS. | |
AR034900A1 (en) | USE OF AN EFFECTIVE AMOUNT OF A PDE4 INHIBITOR AND AN ANTI-POLINERGIC AGENT, WELL IN COMBINED FORM ONLY OR SEPARATELY, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, METHOD TO PREPARE THEM, AND USE OF A COMPOSITION THAT INCLUDES AN EFFECTIVE AMOUNT OF A PDD AN EFFECTIVE AMOUNT | |
CO5650230A2 (en) | STABLE COMPOSITIONS OF ATORVASTATIN PREPARED WITH GRANULATION IN MOISTURE | |
AR036085A1 (en) | DOSAGE FORMS AND PROCEDURE FOR MANUFACTURING | |
HUP0100171A2 (en) | Use of endothelin receptor antagonists for producing pharmaceutical preparations for combating obesity | |
BRPI0511305A (en) | method of relieving an annular or sarcoid granuloma, manufactured article and use of an lfa-1 antagonist | |
UY27599A1 (en) | DIRECTLY COMPRESSIBLE ACITHROMYCIN FORMULATIONS | |
CL2004001317A1 (en) | PHARMACEUTICAL COMPOSITION INCLUDING THE PROGESTERONE RECEIVER ANTAGONIST 11B- (4-ACETILFENIL) -17B-HIDROXI-17 ALFA- (1,1,2,2,2-PENTAFLUOROETIL) -ESTRA-4,9-DIEN-3-ONA AND A PURE ANTIESTROGEN; AND ITS USE TO TREAT A DEPENDENT DISEASE OF H | |
AR039162A1 (en) | VENLAFAXINA FORMULATIONS OF EXTENDED LIBERATION | |
PL378106A1 (en) | Method for producing a pharmaceutical composition in the form of fibrate-containing tablets and tablets produced by said method | |
AR099137A2 (en) | FORMULATION FOR DIRECT COMPRESSION AND PROCESS | |
AR030660A1 (en) | PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF AN ILLNESS ASSOCIATED WITH AN EXCESS OF IL-12 PRODUCTION | |
BR0206272A (en) | Solid unit dosage form comprising citalopram | |
DE602004022578D1 (en) | ANTITUMORAL TERPEN COMPOUNDS | |
AR021719A1 (en) | ANTIESTROGEN ORAL PHARMACEUTICAL COMPOSITION. | |
PL1626726T3 (en) | Use of lornoxicam or lornoxicam analogue compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20150126 |